Toggle navigation
Home
Search
Services
Blog
Contact
About
Development of Antibodies for Drug-Metabolizing Enzymes
Hyesook, Kim
Oxford Biomedical Research, Inc., Rochester Hills, MI, United States
Search 34 grants from Kim Hyesook
Search grants from Oxford Biomedical Research, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
TIE2 Activation for the Treatment of Chemical-Induced Acute Lung Injury
Overcoming Resistance in HER2-positive Breast Cancer
Modulation of Histone Methyltransferases by Xenoestrogens
fMRI Assessment of Organophosphate Neurotoxicity
Computer-Based Montage Slide Making System
Recently added grants:
New tools for antimalarial target identification
Alterations in the surfaceome of the herpes simplex virus 1 infected cells via the Cbl/CIN85 endocytic machinery and the role of the Infected Cell Protein No 0 (ICP0) in endocytosis.
Detection and Activation of CD4+ T cells with Low Affinity TCRs
Antifungal Liposomes Targeted to Cell Wall Mannans
The interface between L. pneumophila manipulation of host endoplasmic reticulum and innate immune subterfuge
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Small Business Innovation Research – Phase I (N43)
Project #
N43ES031002-001
Application #
3639950
Study Section
Project Start
1993-09-30
Project End
Budget Start
1993-12-20
Budget End
1994-03-31
Support Year
Fiscal Year
1994
Total Cost
Indirect Cost
Institution
Name
Oxford Biomedical Research, Inc.
Department
Type
DUNS #
City
Rochester Hills
State
MI
Country
United States
Zip Code
48309
Related projects
NIH 1994
N43 ES
Development of Antibodies for Drug-Metabolizing Enzymes
Hyesook, Kim / Oxford Biomedical Research, Inc.
NIH 1993
N43 ES
Development of Antibodies for Drug Metabolizing Enzymes
Hyesook, Kim / Oxford Biomedical Research, Inc.
Comments
Be the first to comment on Kim Hyesook's grant